Digest Network Come funziona
Network
/
Società
In
Non verificato

Indapta Therapeutics, Inc.

Di cosa scriviamo

BiotecnologiaIndustriaMedicina - VarieOncologiaSalute

4 comunicati stampa

Guarda tutti i comunicati
07/11/2025
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
Indapta Therapeutics Presents Data Demonstrating Clinical Activity of its Allogeneic Natural Killer Cell Therapy in Patients with Relapsed/Refractory Multiple Myeloma
Fonte
Indapta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/12/2024
Mercato del lavoro
Industria
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Indapta Therapeutics Announces Clinical Study Collaboration With Sanofi on Multiple Myeloma Program
Fonte
Indapta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
07/11/2024
Eventi
Industria
Scienza
HIV, AIDS e malattie autoimmuni
Medicina - Varie
Cardiologia
Biotecnologia
Salute
Farmaceutica
Oncologia
Indapta Therapeutics Presents Clinical and Preclinical Data of Allogenic Natural Killer Cell Therapy at Society for Immunotherapy of Cancer Meeting
Fonte
Indapta Therapeutics, Inc.
Emittente
Business Wire
1.00
0
06/08/2024
Scienza
Igiene alimentare
Biotecnologia
Medicina - Varie
Salute
Sanità
Oncologia
Industria
Indapta Therapeutics Announces FDA Clearance of IND for Phase 1 Trial of IDP-023 for Progressive Multiple Sclerosis
Fonte
Indapta Therapeutics, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0